Orphanet Journal of Rare Diseases

Scope & Guideline

Empowering researchers to transform rare disease care.

Introduction

Explore the comprehensive scope of Orphanet Journal of Rare Diseases through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore Orphanet Journal of Rare Diseases in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN-
PublisherBMC
Support Open AccessNo
Country-
Type-
Converge-
AbbreviationORPHANET J RARE DIS / Orphanet J. Rare Dis.
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressCAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND

Aims and Scopes

The Orphanet Journal of Rare Diseases focuses on providing a platform for the dissemination of research related to rare diseases, encompassing clinical, genetic, therapeutic, and epidemiological studies. It aims to improve the understanding of rare diseases and enhance patient care through comprehensive research findings.
  1. Clinical Research on Rare Diseases:
    This includes studies that explore clinical presentations, treatment efficacy, and long-term outcomes of various rare diseases, contributing to improved management and care protocols.
  2. Genetic Characterization and Genomics:
    The journal emphasizes studies that delve into the genetic underpinnings of rare diseases, including mutation analysis, genotype-phenotype correlations, and the use of next-generation sequencing to enhance diagnostic accuracy.
  3. Patient-Centered Outcomes and Quality of Life:
    Research focusing on patient-reported outcomes, quality of life assessments, and the psychosocial impact of rare diseases on patients and their families is a core area, highlighting the importance of patient perspectives in treatment planning.
  4. Health Economics and Burden of Illness:
    The journal publishes studies that assess the economic impact of rare diseases, including cost-of-illness analyses and healthcare utilization, providing insights into the broader implications of these conditions on healthcare systems.
  5. Innovative Therapeutics and Treatment Approaches:
    Research on novel therapeutic interventions, including pharmacological treatments, gene therapies, and clinical trial methodologies to evaluate the effectiveness of new therapies for rare diseases.
  6. Multidisciplinary and Collaborative Approaches:
    The journal promotes interdisciplinary research that involves collaboration among clinicians, researchers, and patients, fostering a holistic approach to the study and management of rare diseases.
The journal is currently witnessing a rise in interest in several themes, reflecting the evolving landscape of rare disease research and its implications for clinical practice.
  1. Telemedicine and Remote Care:
    The COVID-19 pandemic has accelerated interest in telehealth solutions for managing rare diseases, leading to an increase in studies examining the effectiveness of remote consultations and digital health technologies.
  2. Patient Engagement and Advocacy:
    There is a growing focus on the role of patient advocacy groups and their influence on research priorities and treatment development, highlighting the importance of patient voices in shaping healthcare policies.
  3. Longitudinal and Natural History Studies:
    Research tracking the long-term progression of rare diseases is gaining traction, aiming to improve understanding of disease trajectories and inform future therapeutic strategies.
  4. Integration of Artificial Intelligence in Rare Disease Research:
    The application of AI and machine learning in analyzing large datasets for rare diseases is emerging, with studies exploring how these technologies can enhance diagnostics and treatment personalization.
  5. Health Disparities in Rare Diseases:
    An increasing emphasis on understanding the disparities in access to care and treatment outcomes among different populations affected by rare diseases is becoming more prevalent.

Declining or Waning

While the journal has grown and diversified in its research focus, certain themes appear to be declining in prominence over recent years. These waning scopes may reflect shifts in research priorities or advancements in other areas.
  1. Epidemiological Studies of Rare Diseases:
    There has been a noticeable decline in publications solely focused on the epidemiology of rare diseases, possibly due to the increasing integration of epidemiological data into broader studies that also consider genetic and clinical aspects.
  2. Traditional Case Reports:
    The frequency of traditional case reports has diminished as the journal increasingly emphasizes systematic reviews and larger cohort studies that provide more comprehensive data.
  3. Single-Country Focused Studies:
    Research that concentrates on rare diseases within a specific country is becoming less common, as there is a growing trend toward multi-national studies that provide a more global perspective on rare diseases.

Similar Journals

Clinical Medicine & Research

Elevating patient outcomes through community-focused studies.
Publisher: MARSHFIELD CLINICISSN: 1539-4182Frequency: 4 issues/year

Clinical Medicine & Research is a premier peer-reviewed journal published by Marshfield Clinic, dedicated to advancing the field of medical science with a focus on clinical and community-based care. Established in 2003, the journal showcases groundbreaking research and innovative practices aimed at improving patient outcomes and optimizing healthcare delivery. With an ISSN of 1539-4182 and an E-ISSN of 1554-6179, it has garnered recognition in the academic community, achieving a Q2 ranking in Community and Home Care and a Q3 ranking in Miscellaneous Medicine categories as of 2023. The journal’s Scopus rankings further emphasize its relevance, placing it at #263 in General Medicine and #20 in Community and Home Care. Although it operates under a subscription model, Clinical Medicine & Research remains pivotal for researchers, professionals, and students seeking to stay informed about the latest advancements in clinical practice and healthcare methodologies, with an eye toward its impact on the broader medical landscape through 2024 and beyond.

ACTA CLINICA BELGICA

Advancing medical knowledge through peer-reviewed research.
Publisher: TAYLOR & FRANCIS LTDISSN: 1784-3286Frequency: 6 issues/year

ACTA CLINICA BELGICA is a distinguished peer-reviewed journal published by Taylor & Francis Ltd that has been a vital contributor to the field of general medicine since its inception in 1946. With an ISSN of 1784-3286 and an E-ISSN of 2295-3337, it serves as an essential platform for disseminating novel research and clinical advancements. The journal is currently ranked in the 3rd quartile (Q3) of the Medicine (miscellaneous) category, placing it at an impressive 76th percentile among its peers in the Scopus database, which reflects its importance in the medical community. Although it does not offer Open Access options, ACTA CLINICA BELGICA provides a comprehensive overview of contemporary research, clinical practices, and medical innovations, making it a crucial resource for researchers, healthcare professionals, and students committed to enhancing their knowledge and practices.

SAGE Open Medical Case Reports

Fostering Collaboration Through Shared Medical Knowledge
Publisher: SAGE PUBLICATIONS INCISSN: 2050-313XFrequency: 1 issue/year

SAGE Open Medical Case Reports, published by SAGE Publications Inc, is a pioneering open-access journal dedicated to the rapid dissemination of medical case reports that significantly contribute to clinical knowledge and practice. Since its launch in 2013, this journal has become a valuable resource for healthcare professionals, researchers, and students in the field of medicine, facilitating the exchange of unique clinical experiences from around the globe. While the journal is categorized as Q4 in the Medicine (miscellaneous) quartile and holds a Scopus rank of 423 out of 636 in the General Medicine category, the accessibility of its content underscores its commitment to enhancing medical education and informing practice. With no subscription barriers, it supports the sharing of critical insights appropriate to a diverse audience, thereby fostering a culture of innovation and collaboration in healthcare.

Biomedical Reports

Connecting disciplines to unlock biomedical breakthroughs.
Publisher: SPANDIDOS PUBL LTDISSN: 2049-9434Frequency: 6 issues/year

Biomedical Reports, published by SPANDIDOS PUBL LTD in Greece, is a distinguished open-access journal that focuses on the dynamic fields of biochemistry, genetics, molecular biology, medicine, pharmacology, and neuroscience. Established in 2014, the journal has rapidly gained recognition, securing Q2 and Q3 rankings in several categories for 2023, including a notable ranking of #125/636 in General Medicine, placing it in the 80th percentile amongst its peers. The journal continually aims to disseminate innovative research findings that advance the understanding of complex biomedical issues, making it an invaluable resource for researchers, professionals, and students alike. Its multidisciplinary approach not only reflects the interconnectivity of modern biomedical sciences but also promotes collaborative discourse among diverse fields, ensuring ongoing relevance and impact within the scientific community.

Pulmonary Circulation

Innovating solutions for lung health challenges.
Publisher: WILEYISSN: 2045-8932Frequency: 4 issues/year

Pulmonary Circulation is a leading open-access journal published by Wiley, focused on advancing the field of pulmonary and respiratory medicine. Established in 2011, the journal has garnered a prestigious reputation, achieving a Q2 ranking in 2023 among its category and ranking #70 out of 155 in Scopus within the specialty of Medicine – Pulmonary and Respiratory Medicine, reflecting its growing influence and relevance in the scientific community. With its commitment to delivering high-quality, peer-reviewed research, Pulmonary Circulation serves as a vital resource for researchers, clinicians, and students seeking to explore innovative ideas and findings in lung health, pulmonary vascular diseases, and therapeutic approaches. The journal has been open access since 2017, ensuring that groundbreaking research is accessible to a wider audience, thus promoting collaboration and knowledge exchange in this dynamic field. Located in the heart of the United States at 111 River St, Hoboken, NJ 07030-5774, the journal is dedicated to fostering advancements in pulmonary health and addressing real-world challenges facing patients globally.

Cold Spring Harbor Molecular Case Studies

Empowering researchers with impactful case studies.
Publisher: COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPTISSN: 2373-2873Frequency: 6 issues/year

Cold Spring Harbor Molecular Case Studies is a prestigious journal published by COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT, that has garnered considerable attention in the fields of Biochemistry, Genetics, and Molecular Medicine. With a focus on the intersection of molecular biology and clinical case studies, this journal serves as a key resource for researchers and practitioners seeking to explore novel insights into genetic disorders and biomedical advances. Its impact is underscored by its categorization in Q2 in various disciplines in 2023, reflecting its significance and influence within the academic community. Although currently not labeled as Open Access, Cold Spring Harbor Molecular Case Studies provides a rigorous platform for disseminating high-quality, peer-reviewed research that drives innovation and enhances understanding in these rapidly evolving fields. As a supporter of advancing scientific knowledge, this journal is essential for those dedicated to the exploration of molecular mechanisms and their clinical implications.

Case Reports in Medicine

Exploring the nuances of medicine through compelling case reports.
Publisher: HINDAWI LTDISSN: 1687-9627Frequency: 1 issue/year

Case Reports in Medicine is a distinguished journal published by HINDAWI LTD, focusing on the vital field of medical case studies and reports. Since its inception in 2009, this Open Access journal has offered a platform for sharing novel insights, challenges, and outcomes encountered in clinical practice. Located in the United States, it serves a global audience of researchers and healthcare professionals, emphasizing the importance of case reports in advancing medical knowledge and promoting evidence-based practice. With an impressive ranking of Q3 in Medicine (miscellaneous) and a solid performance at #265/636 in General Medicine (58th percentile) as per Scopus, the journal is recognized for its impactful contributions to the medical community. Through its commitment to disseminating quality research, Case Reports in Medicine plays a crucial role in fostering collaboration and enhancing patient care worldwide, making it an essential resource for students, researchers, and practitioners alike.

Open Access Rheumatology-Research and Reviews

Pioneering Open Access Research in Rheumatology.
Publisher: DOVE MEDICAL PRESS LTDISSN: 1179-156XFrequency: 1 issue/year

Open Access Rheumatology-Research and Reviews, published by DOVE MEDICAL PRESS LTD, is a distinguished journal that has been a vital part of the rheumatology field since its inception in 2009. With an ISSN of 1179-156X, this journal is dedicated to disseminating groundbreaking research and comprehensive reviews in the discipline of rheumatology, making it an essential resource for researchers, clinicians, and students alike. It boasts an impressive Q3 ranking in the Rheumatology category for 2023, reflecting its relevance and quality within a highly competitive landscape, where it ranks in the 51st percentile among its peers as indicated by the Scopus Ranks. As an open-access platform, it ensures that critical findings and insights are easily accessible to a global audience, promoting collaboration and knowledge sharing. The journal's scope includes a wide range of topics within rheumatology, aimed at advancing understanding and treatment of musculoskeletal disorders and autoimmune diseases. Its headquarters is located in New Zealand, positioning it as a key player in the international research community.

European Journal of Medical Genetics

Transforming Research into Clinical Realities
Publisher: ELSEVIERISSN: 1769-7212Frequency: 4 issues/year

European Journal of Medical Genetics, published by Elsevier, is a pivotal platform dedicated to advancing knowledge in the fields of medical genetics and its clinical applications. With an ISSN of 1769-7212 and an E-ISSN of 1878-0849, this journal fosters innovative research and insights into the genetic factors that influence human health. Ranked in the Q3 category for both Genetics and Clinical Genetics, and achieving notable recognition in Medicine (miscellaneous) with a Q2 positioning, it strives to bridge the gap between laboratory findings and clinical practice. Operating in an Open Access format, the journal aims at maximally disseminating essential findings to researchers, professionals, and students alike, ensuring that critical advances in genetics are accessible to the global medical community. With converged publication years spanning from 2005 to 2024, the journal strengthens its mission to be at the forefront of genetic research that informs clinical methodologies and fosters improved healthcare outcomes.

Boletin de Pediatria

Innovating Child Health: Where Research Meets Practice
Publisher: EDICIONES ERGON SAISSN: 0214-2597Frequency: 4 issues/year

Boletin de Pediatria is a distinguished journal dedicated to the field of pediatric medicine, serving as a valuable resource for researchers, clinicians, and students alike. Published by EDICIONES ERGON SA, this journal is committed to advancing the knowledge and practice of pediatric healthcare. With its ISSN 0214-2597 and E-ISSN 2340-5384, it strives to disseminate high-quality, peer-reviewed research that addresses the latest advancements and best practices in pediatrics. Although specific impact factor data is not currently available, the journal's rigorous publication standards maintain its reputation within the scientific community. Notably, while Boletin de Pediatria is not an open-access journal, it provides digital access options that ensure the wide distribution of critical pediatric research. With a commitment to improving child health outcomes, this journal plays an essential role in fostering innovation and collaboration among pediatric healthcare professionals globally.